Advertisement

Reactions Weekly

, Volume 1766, Issue 1, pp 293–293 | Cite as

Venetoclax

Tumour lysis syndrome and neutropenia: 3 case reports
Case report
  • 12 Downloads

Reference

  1. Roeker LE, et al. Tumor lysis, adverse events, and dose adjustments in 297 venetoclax-treated CLL patients in routine clinical practice. Clinical Cancer Research 25: 4264-4270, No. 14, Jul 2019. Available from: URL: http://doi.org/10.1158/1078-0432.CCR-19-0361 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations